CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 77 filers reported holding CULLINAN ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $879,288 | -6.3% | 97,159 | +11.5% | 0.00% | – |
| Q2 2023 | $937,949 | -4.7% | 87,170 | -9.4% | 0.00% | – |
| Q1 2023 | $984,536 | -14.4% | 96,240 | -11.7% | 0.00% | – |
| Q4 2022 | $1,150,066 | -15.2% | 109,011 | +3.0% | 0.00% | – |
| Q3 2022 | $1,357,000 | +14.7% | 105,878 | +14.7% | 0.00% | – |
| Q2 2022 | $1,183,000 | +21.3% | 92,304 | -0.9% | 0.00% | – |
| Q1 2022 | $975,000 | -33.8% | 93,184 | -2.3% | 0.00% | – |
| Q4 2021 | $1,473,000 | -18.6% | 95,423 | +19.0% | 0.00% | – |
| Q3 2021 | $1,810,000 | +77.5% | 80,164 | +102.3% | 0.00% | – |
| Q2 2021 | $1,020,000 | -29.7% | 39,627 | +13.8% | 0.00% | – |
| Q1 2021 | $1,451,000 | – | 34,825 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |